• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一篇关于生物可吸收血管支架早期和晚期反复血栓形成的病例报告:系列血管造影和光学相干断层成像发现。

A case report of a recurrent early and late Bioresorbable vascular scaffold thrombosis: serial angiography and optical coherence tomography findings.

机构信息

Division of Cardiology, Keimyung University Dongsan Medical Center, 56 Dalseong-Ro, Jung-Gu, Daegu, 700-712, South Korea.

出版信息

BMC Cardiovasc Disord. 2020 Mar 24;20(1):146. doi: 10.1186/s12872-020-01426-z.

DOI:10.1186/s12872-020-01426-z
PMID:32204697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7092538/
Abstract

BACKGROUND

In bioresorbable vascular scaffolds (BVSs), there is some concern about a possible increase in the rate of scaffold thromboses (ScTs). Although several characteristics similarly contribute to the development of both early and late ScTs, there are also clearly different pathomechanisms between the two time-dependent types of thromboses, especially with BVSs.

CASE PRESENTATION

We recently experienced a very rare case of a 69-year-old man who had recurrent early and late ScTs with somewhat differing pathomechanisms as assessed by optical coherence tomography (OCT). For the late ScT, OCT identified a scaffold dismantling in the same place that a peri-strut low intensity area (PLIA) was observed in the previous OCT finding.

CONCLUSION

We report the management of an ScT in a case with findings such as a heterogeneous a BVS degradation, peri-strut low intensity area (PLIA), intraluminal scaffold dismantling, and under-sizing and/or stent malapposition observed in OCT.

摘要

背景

在生物可吸收血管支架(BVS)中,人们对支架内血栓形成(ScT)的发生率增加存在一些担忧。尽管有几个特征同样有助于早期和晚期 ScT 的发生,但这两种依赖时间的血栓形成之间显然存在不同的病理机制,尤其是在 BVS 中。

病例介绍

我们最近遇到了一个非常罕见的病例,一名 69 岁男性反复发生早期和晚期 ScT,通过光学相干断层扫描(OCT)评估,其病理机制有些不同。对于晚期 ScT,OCT 发现支架在同一位置解体,而在前一次 OCT 发现中观察到支架内低强度区域(PLIA)。

结论

我们报告了一例 ScT 的处理情况,该病例的 OCT 检查结果显示 BVS 降解不均匀、支架内低强度区域(PLIA)、管腔内支架解体、支架尺寸过小和/或支架贴壁不良。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/d72d6eec444e/12872_2020_1426_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/4389517ef5eb/12872_2020_1426_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/a78a14d84e23/12872_2020_1426_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/f7615c778b95/12872_2020_1426_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/0760be2bbb96/12872_2020_1426_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/d72d6eec444e/12872_2020_1426_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/4389517ef5eb/12872_2020_1426_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/a78a14d84e23/12872_2020_1426_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/f7615c778b95/12872_2020_1426_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/0760be2bbb96/12872_2020_1426_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc9/7092538/d72d6eec444e/12872_2020_1426_Fig5_HTML.jpg

相似文献

1
A case report of a recurrent early and late Bioresorbable vascular scaffold thrombosis: serial angiography and optical coherence tomography findings.一篇关于生物可吸收血管支架早期和晚期反复血栓形成的病例报告:系列血管造影和光学相干断层成像发现。
BMC Cardiovasc Disord. 2020 Mar 24;20(1):146. doi: 10.1186/s12872-020-01426-z.
2
Randomized Comparison Between Everolimus-Eluting Bioresorbable Scaffold and Metallic Stent: Multimodality Imaging Through 3 Years.随机比较依维莫司洗脱生物可吸收支架与金属支架:3 年多模态成像。
JACC Cardiovasc Interv. 2020 Jan 13;13(1):116-127. doi: 10.1016/j.jcin.2019.09.047.
3
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果:ABSORB 队列 B 试验的光学相干断层成像评估(生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
4
Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis.重叠区域的生物可吸收血管支架断裂是加速新生动脉粥样硬化和支架内极晚期血栓形成的原因。
Int J Cardiovasc Imaging. 2017 Jan;33(1):1-3. doi: 10.1007/s10554-016-0967-0. Epub 2016 Aug 25.
5
Routine use of optical coherence tomography in bioresorbable vascular scaffold implantation: insights on technique optimization and long-term outcomes.光学相干断层扫描在生物可吸收血管支架植入中的常规应用:技术优化及长期结果的见解
Coron Artery Dis. 2019 Jun;30(4):263-269. doi: 10.1097/MCA.0000000000000736.
6
Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomography.在常规临床实践中植入ABSORB生物可吸收支架后发生的支架内血栓形成:基于光学相干断层扫描对可能机制的深入了解。
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):E106-E114. doi: 10.1002/ccd.27475. Epub 2018 Jan 14.
7
Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.用于复发性支架内再狭窄而植入的生物可吸收血管支架的亚急性血栓形成。
EuroIntervention. 2015 Nov;11(7):780. doi: 10.4244/EIJY14M10_07.
8
Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.血管造影和光学相干断层扫描对生物可吸收支架血栓形成的见解:单中心经验
Circ Cardiovasc Interv. 2015 May;8(5). doi: 10.1161/CIRCINTERVENTIONS.114.002369.
9
ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.可吸收生物降解支架与第二代金属支架比较:100 例 OCT 指导下复杂病变治疗的对比研究。
JACC Cardiovasc Interv. 2014 Jul;7(7):741-50. doi: 10.1016/j.jcin.2014.01.165.
10
Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.光学相干断层成像术对头对头比较金属和生物可吸收依维莫司洗脱支架的新生内膜反应。
JACC Cardiovasc Interv. 2011 Dec;4(12):1271-80. doi: 10.1016/j.jcin.2011.08.016.

引用本文的文献

1
Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials.生物可吸收支架与药物洗脱支架用于心肌梗死患者的比较:随机临床试验的系统评价和荟萃分析
Front Cardiovasc Med. 2022 Oct 28;9:974957. doi: 10.3389/fcvm.2022.974957. eCollection 2022.

本文引用的文献

1
Effect of Technique on Outcomes Following Bioresorbable Vascular Scaffold Implantation: Analysis From the ABSORB Trials.生物可吸收血管支架置入术后技术对结局的影响:ABSORB 试验分析。
J Am Coll Cardiol. 2017 Dec 12;70(23):2863-2874. doi: 10.1016/j.jacc.2017.09.1106. Epub 2017 Oct 31.
2
Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.急性、亚急性和晚期吸收支架血栓形成的临床、血管造影和操作相关性。
JACC Cardiovasc Interv. 2017 Sep 25;10(18):1809-1815. doi: 10.1016/j.jcin.2017.06.067.
3
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.
生物可吸收支架与金属支架在常规 PCI 中的应用比较。
N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.
4
Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.极晚期支架血栓:冠状动脉内影像学及组织病理学和光谱学研究结果。
J Am Coll Cardiol. 2015 Oct 27;66(17):1901-14. doi: 10.1016/j.jacc.2015.08.853.
5
Optical Coherence Tomography Findings in Bioresorbable Vascular Scaffolds Thrombosis.生物可吸收血管支架血栓形成的光学相干断层扫描结果
Circ Cardiovasc Interv. 2015 Oct;8(10):e002518. doi: 10.1161/CIRCINTERVENTIONS.114.002518.
6
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).2015年欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠脉综合征患者管理指南:欧洲心脏病学会(ESC)非持续性ST段抬高型急性冠脉综合征患者管理工作组
Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29.
7
Treatment of bioresorbable scaffold failure.
EuroIntervention. 2015;11 Suppl V:V175-80. doi: 10.4244/EIJV11SVA42.
8
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective.当代经皮冠状动脉介入治疗中生物可吸收支架的应用及技术要点:欧洲视角。
EuroIntervention. 2015 May;11(1):45-52. doi: 10.4244/EIJY15M01_05.
9
Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction.早期微血管功能的侵入性指标变化可预测 ST 段抬高型心肌梗死经皮冠状动脉介入治疗后的心肌恢复。
Eur Heart J. 2014 Aug 1;35(29):1971-80. doi: 10.1093/eurheartj/eht434. Epub 2013 Oct 17.
10
Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction.在 ST 段抬高型心肌梗死再灌注期间,血浆神经肽 Y 与血管造影、心电图和冠状动脉生理学指标的关系。
Heart. 2013 Aug;99(16):1198-203. doi: 10.1136/heartjnl-2012-303443. Epub 2013 Feb 12.